$2.69
-1.48-35.61%
Last update: Nov 9, 11:05 AM
Abeona Therapeutics Inc (ABEO) Stock Price, Quote, News & History
ABEONASDAQ
Abeona beats EPS estimates but misses revenue, acquires ABO-801, raises $30M, and reports growing ZEVASKYN sales and Medicare support.
You can purchase shares of Abeona Therapeutics (NASDAQ:ABEO) through any online brokerage.
Other companies in Abeona Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Abeona Therapeutics has a consensus price target of $19.88.
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $2.685 last updated November 9, 2026 at 11:05 AM EST.
There are no upcoming dividends for Abeona Therapeutics.
Abeona Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Abeona Therapeutics.
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene...
